Zaltoprofen

Zaltoprofen (JAN; trade name Soleton) is a nonsteroidal anti-inflammatory drug (NSAID) used as an analgesic, antipyretic, and anti-inflammatory agent.[1] It is a selective COX-2 inhibitor and also inhibits bradykinin-induced pain responses without blocking bradykinin receptors.[2]

Zaltoprofen

Clinical data
Trade names	Soleton
Other names	Zaxoprofen
Drug class	NSAID
Legal status
Legal status	US: Not FDA approved Japan: Rx-only
Identifiers
IUPAC name 2-(6-Oxo-5H-benzo[b][1]benzothiepin-3-yl)propanoic acid
CAS Number	74711-43-6
PubChem CID	5720
DrugBank	DB06737
UNII	H8635NG3PY
CompTox Dashboard (EPA)	DTXSID0049076
ECHA InfoCard	100.070.863
Chemical and physical data
Formula	C17H14O3S
Molar mass	298.36 g·mol^−1
3D model (JSmol)	Interactive image
SMILES CC(C1=CC2=C(C=C1)SC3=CC=CC=C3C(=O)C2)C(=O)O

It was approved for use in Japan in 1993.[3]

References

1. "Zaltoprofen". drugs.com.
2. Hirate K, Uchida A, Ogawa Y, Arai T, Yoda K (April 2006). "Zaltoprofen, a non-steroidal anti-inflammatory drug, inhibits bradykinin-induced pain responses without blocking bradykinin receptors". Neuroscience Research. 54 (4): 288–94. doi:10.1016/j.neures.2005.12.016. PMID 16473424.
3. "Zaltoprofen Launched in Japan". thepharmaletter.com. September 20, 1993.